Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Clinical and pathological characteristics of a series of patients with newly diagnosed primary renal liposarcoma: natural history and effect on survival.

Fichera D, Luciano R, Nini A, Freschi M, Doglioni C, Bertini R, Montorsi F, Capitanio U.

Arch Esp Urol. 2018 Jul;71(6):555-558. Review.

PMID:
29991665
2.

Pathological High-risk Renal Cell Carcinoma: Trends in Clinical Characteristics Over 25 Years.

DI Trapani E, Dell'oglio P, Larcher A, Nini A, Muttin F, Cianflone F, Dehò F, Matloob R, DI Trapani D, Freschi M, Salonia A, Briganti A, Montorsi F, Bertini R, Capitanio U.

Anticancer Res. 2018 Jul;38(7):4123-4130. doi: 10.21873/anticanres.12703.

PMID:
29970539
3.

Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell Therapy.

Elia AR, Grioni M, Basso V, Curnis F, Freschi M, Corti A, Mondino A, Bellone M.

Clin Cancer Res. 2018 May 1;24(9):2171-2181. doi: 10.1158/1078-0432.CCR-17-2210. Epub 2018 Feb 28.

PMID:
29490991
4.

Beyond the Required LISA Free-Fall Performance: New LISA Pathfinder Results down to 20  μHz.

Armano M, Audley H, Baird J, Binetruy P, Born M, Bortoluzzi D, Castelli E, Cavalleri A, Cesarini A, Cruise AM, Danzmann K, de Deus Silva M, Diepholz I, Dixon G, Dolesi R, Ferraioli L, Ferroni V, Fitzsimons ED, Freschi M, Gesa L, Gibert F, Giardini D, Giusteri R, Grimani C, Grzymisch J, Harrison I, Heinzel G, Hewitson M, Hollington D, Hoyland D, Hueller M, Inchauspé H, Jennrich O, Jetzer P, Karnesis N, Kaune B, Korsakova N, Killow CJ, Lobo JA, Lloro I, Liu L, López-Zaragoza JP, Maarschalkerweerd R, Mance D, Meshksar N, Martín V, Martin-Polo L, Martino J, Martin-Porqueras F, Mateos I, McNamara PW, Mendes J, Mendes L, Nofrarias M, Paczkowski S, Perreur-Lloyd M, Petiteau A, Pivato P, Plagnol E, Ramos-Castro J, Reiche J, Robertson DI, Rivas F, Russano G, Slutsky J, Sopuerta CF, Sumner T, Texier D, Thorpe JI, Vetrugno D, Vitale S, Wanner G, Ward H, Wass PJ, Weber WJ, Wissel L, Wittchen A, Zweifel P.

Phys Rev Lett. 2018 Feb 9;120(6):061101. doi: 10.1103/PhysRevLett.120.061101.

5.

Preoperative multiparametric MRI of the prostate for the prediction of lymph node metastases in prostate cancer patients treated with extended pelvic lymph node dissection.

Brembilla G, Dell'Oglio P, Stabile A, Ambrosi A, Cristel G, Brunetti L, Damascelli A, Freschi M, Esposito A, Briganti A, Montorsi F, Del Maschio A, De Cobelli F.

Eur Radiol. 2018 May;28(5):1969-1976. doi: 10.1007/s00330-017-5229-6. Epub 2017 Dec 21.

PMID:
29270644
6.

Multiple intracerebroventricular injections of human umbilical cord mesenchymal stem cells delay motor neurons loss but not disease progression of SOD1G93A mice.

Sironi F, Vallarola A, Violatto MB, Talamini L, Freschi M, De Gioia R, Capelli C, Agostini A, Moscatelli D, Tortarolo M, Bigini P, Introna M, Bendotti C.

Stem Cell Res. 2017 Dec;25:166-178. doi: 10.1016/j.scr.2017.11.005. Epub 2017 Nov 10.

7.

Identifying candidates for super-extended staging pelvic lymph node dissection among patients with high-risk prostate cancer.

Gandaglia G, Zaffuto E, Fossati N, Bandini M, Suardi N, Mazzone E, Dell'Oglio P, Stabile A, Freschi M, Montorsi F, Briganti A.

BJU Int. 2018 Mar;121(3):421-427. doi: 10.1111/bju.14066. Epub 2017 Nov 27.

PMID:
29063734
8.

Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for Renal Cell Carcinoma Invading the Supradiaphragmatic Inferior Vena Cava and/or Right Atrium.

Nini A, Capitanio U, Larcher A, Dell'Oglio P, Dehò F, Suardi N, Muttin F, Carenzi C, Freschi M, Lucianò R, La Croce G, Briganti A, Colombo R, Salonia A, Castiglioni A, Rigatti P, Montorsi F, Bertini R.

Eur Urol. 2018 May;73(5):793-799. doi: 10.1016/j.eururo.2017.08.019. Epub 2017 Sep 13.

PMID:
28917595
9.

In reply to: Lawless et al. Stalk versus base invasion in pT1 papillary cancers of the bladder: improved substaging system predicting the risk of progression.

Patriarca C, Hurle R, Colombo P, Colecchia M, Freschi M, Conti G, Petracco G, Colombo R.

Histopathology. 2018 Jan;72(2):361-362. doi: 10.1111/his.13374. Epub 2017 Oct 27. No abstract available.

PMID:
28851130
10.

PD-L1 Expression and CD8+ T-cell Infiltrate are Associated with Clinical Progression in Patients with Node-positive Prostate Cancer.

Petitprez F, Fossati N, Vano Y, Freschi M, Becht E, Lucianò R, Calderaro J, Guédet T, Lacroix L, Rancoita PMV, Montorsi F, Fridman WH, Sautès-Fridman C, Briganti A, Doglioni C, Bellone M.

Eur Urol Focus. 2017 Jun 21. pii: S2405-4569(17)30151-7. doi: 10.1016/j.euf.2017.05.013. [Epub ahead of print]

PMID:
28753812
11.

Feasibility and Clinical Roles of Different Substaging Systems at First and Second Transurethral Resection in Patients with T1 High-Grade Bladder Cancer.

Colombo R, Hurle R, Moschini M, Freschi M, Colombo P, Colecchia M, Ferrari L, Lucianò R, Conti G, Magnani T, Capogrosso P, Conti A, Pasini L, Burgio G, Guazzoni G, Patriarca C.

Eur Urol Focus. 2018 Jan;4(1):87-93. doi: 10.1016/j.euf.2016.06.004. Epub 2016 Jun 15.

PMID:
28753746
12.

Charge-Induced Force Noise on Free-Falling Test Masses: Results from LISA Pathfinder.

Armano M, Audley H, Auger G, Baird JT, Binetruy P, Born M, Bortoluzzi D, Brandt N, Bursi A, Caleno M, Cavalleri A, Cesarini A, Cruise M, Danzmann K, de Deus Silva M, Diepholz I, Dolesi R, Dunbar N, Ferraioli L, Ferroni V, Fitzsimons ED, Flatscher R, Freschi M, Gallegos J, García Marirrodriga C, Gerndt R, Gesa L, Gibert F, Giardini D, Giusteri R, Grimani C, Grzymisch J, Harrison I, Heinzel G, Hewitson M, Hollington D, Hueller M, Huesler J, Inchauspé H, Jennrich O, Jetzer P, Johlander B, Karnesis N, Kaune B, Killow CJ, Korsakova N, Lloro I, Liu L, López-Zaragoza JP, Maarschalkerweerd R, Madden S, Mance D, Martín V, Martin-Polo L, Martino J, Martin-Porqueras F, Mateos I, McNamara PW, Mendes J, Mendes L, Moroni A, Nofrarias M, Paczkowski S, Perreur-Lloyd M, Petiteau A, Pivato P, Plagnol E, Prat P, Ragnit U, Ramos-Castro J, Reiche J, Romera Perez JA, Robertson DI, Rozemeijer H, Rivas F, Russano G, Sarra P, Schleicher A, Slutsky J, Sopuerta C, Sumner TJ, Texier D, Thorpe JI, Trenkel C, Vetrugno D, Vitale S, Wanner G, Ward H, Wass PJ, Wealthy D, Weber WJ, Wittchen A, Zanoni C, Ziegler T, Zweifel P; LISA Pathfinder Collaboration.

Phys Rev Lett. 2017 Apr 28;118(17):171101. doi: 10.1103/PhysRevLett.118.171101. Epub 2017 Apr 26.

13.

Is transurethral resection alone enough for the diagnosis of histological variants? A single-center study.

Moschini M, Shariat SF, Freschi M, Soria F, D'Andrea D, Abufaraj M, Foerster B, Dell'Oglio P, Zaffuto E, Mattei A, Salonia A, Montorsi F, Briganti A, Gallina A, Colombo R.

Urol Oncol. 2017 Aug;35(8):528.e1-528.e5. doi: 10.1016/j.urolonc.2017.03.024. Epub 2017 Apr 19.

PMID:
28433471
14.

Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.

Gandaglia G, Fossati N, Zaffuto E, Bandini M, Dell'Oglio P, Bravi CA, Fallara G, Pellegrino F, Nocera L, Karakiewicz PI, Tian Z, Freschi M, Montironi R, Montorsi F, Briganti A.

Eur Urol. 2017 Oct;72(4):632-640. doi: 10.1016/j.eururo.2017.03.049. Epub 2017 Apr 12.

PMID:
28412062
15.

Impact of Prostate Involvement on Outcomes in Patients Treated with Radical Cystoprostatectomy for Bladder Cancer.

Moschini M, Shariat SF, Freschi M, Soria F, Abufaraj M, Gandaglia G, Dell'Oglio P, Mattei A, Damiano R, Salonia A, Montorsi F, Briganti A, Gallina A, Colombo R.

Urol Int. 2017;98(3):290-297. doi: 10.1159/000454736. Epub 2017 Feb 1.

PMID:
28142141
16.

Targeting Extracellular Cyclophilin A Reduces Neuroinflammation and Extends Survival in a Mouse Model of Amyotrophic Lateral Sclerosis.

Pasetto L, Pozzi S, Castelnovo M, Basso M, Estevez AG, Fumagalli S, De Simoni MG, Castellaneta V, Bigini P, Restelli E, Chiesa R, Trojsi F, Monsurrò MR, Callea L, Malešević M, Fischer G, Freschi M, Tortarolo M, Bendotti C, Bonetto V.

J Neurosci. 2017 Feb 8;37(6):1413-1427. doi: 10.1523/JNEUROSCI.2462-16.2016. Epub 2016 Dec 23.

17.

T Cells Redirected to a Minor Histocompatibility Antigen Instruct Intratumoral TNFα Expression and Empower Adoptive Cell Therapy for Solid Tumors.

Manzo T, Sturmheit T, Basso V, Petrozziello E, Hess Michelini R, Riba M, Freschi M, Elia AR, Grioni M, Curnis F, Protti MP, Schumacher TN, Debets R, Swartz MA, Corti A, Bellone M, Mondino A.

Cancer Res. 2017 Feb 1;77(3):658-671. doi: 10.1158/0008-5472.CAN-16-0725. Epub 2016 Nov 21.

18.

Sub-Femto-g Free Fall for Space-Based Gravitational Wave Observatories: LISA Pathfinder Results.

Armano M, Audley H, Auger G, Baird JT, Bassan M, Binetruy P, Born M, Bortoluzzi D, Brandt N, Caleno M, Carbone L, Cavalleri A, Cesarini A, Ciani G, Congedo G, Cruise AM, Danzmann K, de Deus Silva M, De Rosa R, Diaz-Aguiló M, Di Fiore L, Diepholz I, Dixon G, Dolesi R, Dunbar N, Ferraioli L, Ferroni V, Fichter W, Fitzsimons ED, Flatscher R, Freschi M, García Marín AF, García Marirrodriga C, Gerndt R, Gesa L, Gibert F, Giardini D, Giusteri R, Guzmán F, Grado A, Grimani C, Grynagier A, Grzymisch J, Harrison I, Heinzel G, Hewitson M, Hollington D, Hoyland D, Hueller M, Inchauspé H, Jennrich O, Jetzer P, Johann U, Johlander B, Karnesis N, Kaune B, Korsakova N, Killow CJ, Lobo JA, Lloro I, Liu L, López-Zaragoza JP, Maarschalkerweerd R, Mance D, Martín V, Martin-Polo L, Martino J, Martin-Porqueras F, Madden S, Mateos I, McNamara PW, Mendes J, Mendes L, Monsky A, Nicolodi D, Nofrarias M, Paczkowski S, Perreur-Lloyd M, Petiteau A, Pivato P, Plagnol E, Prat P, Ragnit U, Raïs B, Ramos-Castro J, Reiche J, Robertson DI, Rozemeijer H, Rivas F, Russano G, Sanjuán J, Sarra P, Schleicher A, Shaul D, Slutsky J, Sopuerta CF, Stanga R, Steier F, Sumner T, Texier D, Thorpe JI, Trenkel C, Tröbs M, Tu HB, Vetrugno D, Vitale S, Wand V, Wanner G, Ward H, Warren C, Wass PJ, Wealthy D, Weber WJ, Wissel L, Wittchen A, Zambotti A, Zanoni C, Ziegler T, Zweifel P.

Phys Rev Lett. 2016 Jun 10;116(23):231101. doi: 10.1103/PhysRevLett.116.231101. Epub 2016 Jun 7.

19.

Apparent diffusion coefficient in the evaluation of side-specific extracapsular extension in prostate cancer: Development and external validation of a nomogram of clinical use.

Giganti F, Coppola A, Ambrosi A, Ravelli S, Esposito A, Freschi M, Briganti A, Scattoni V, Salonia A, Gallina A, Dehò F, Cardone G, Balconi G, Gaboardi F, Montorsi F, Maschio AD, De Cobelli F.

Urol Oncol. 2016 Jul;34(7):291.e9-291.e17. doi: 10.1016/j.urolonc.2016.02.015. Epub 2016 Mar 15.

PMID:
26992933
20.

ALS mouse model SOD1G93A displays early pathology of sensory small fibers associated to accumulation of a neurotoxic splice variant of peripherin.

Sassone J, Taiana M, Lombardi R, Porretta-Serapiglia C, Freschi M, Bonanno S, Marcuzzo S, Caravello F, Bendotti C, Lauria G.

Hum Mol Genet. 2016 Apr 15;25(8):1588-99. doi: 10.1093/hmg/ddw035. Epub 2016 Feb 9.

PMID:
26908600
21.

Usefulness of pT1 substaging in papillary urothelial bladder carcinoma.

Patriarca C, Hurle R, Moschini M, Freschi M, Colombo P, Colecchia M, Ferrari L, Guazzoni G, Conti A, Conti G, Lucianò R, Magnani T, Colombo R.

Diagn Pathol. 2016 Jan 20;11:6. doi: 10.1186/s13000-016-0466-6.

22.

New Insights on the Mechanisms of Disease Course Variability in ALS from Mutant SOD1 Mouse Models.

Nardo G, Trolese MC, Tortarolo M, Vallarola A, Freschi M, Pasetto L, Bonetto V, Bendotti C.

Brain Pathol. 2016 Mar;26(2):237-47. doi: 10.1111/bpa.12351. Review.

PMID:
26780365
23.

Lymphadenopathies in patients with renal cell carcinoma: clinical and pathological predictors of pathologically confirmed lymph node invasion.

Capitanio U, Deho' F, Dell'Oglio P, Larcher A, Capogrosso P, Nini A, Carenzi C, Freschi M, Briganti A, Salonia A, Montorsi F, Bertini R.

World J Urol. 2016 Aug;34(8):1139-45. doi: 10.1007/s00345-015-1747-5. Epub 2015 Dec 15.

PMID:
26670425
24.

Synthetic and natural small molecule TLR4 antagonists inhibit motoneuron death in cultures from ALS mouse model.

De Paola M, Sestito SE, Mariani A, Memo C, Fanelli R, Freschi M, Bendotti C, Calabrese V, Peri F.

Pharmacol Res. 2016 Jan;103:180-7. doi: 10.1016/j.phrs.2015.11.020. Epub 2015 Nov 27.

PMID:
26640075
25.

Muscle Injuries: A Brief Guide to Classification and Management.

Maffulli N, Del Buono A, Oliva F, Giai Via A, Frizziero A, Barazzuol M, Brancaccio P, Freschi M, Galletti S, Lisitano G, Melegati G, Nanni G, Pasta G, Ramponi C, Rizzo D, Testa V, Valent A.

Transl Med UniSa. 2014 Sep 1;12:14-8. eCollection 2015 May-Aug.

26.

Effect on postoperative survival of the status of distal ureteral margin: The necessity to achieve negative margins at the time of radical cystectomy.

Moschini M, Gallina A, Freschi M, Luzzago S, Fossati N, Gandaglia G, Dell'oglio P, Damiano R, Serretta V, Salonia A, Montorsi F, Briganti A, Colombo R.

Urol Oncol. 2016 Feb;34(2):59.e15-22. doi: 10.1016/j.urolonc.2015.09.001. Epub 2015 Oct 9.

PMID:
26482391
27.

Evaluation of positive surgical margins in patients undergoing robot-assisted and open radical prostatectomy according to preoperative risk groups.

Suardi N, Dell'Oglio P, Gallina A, Gandaglia G, Buffi N, Moschini M, Fossati N, Lughezzani G, Karakiewicz PI, Freschi M, Lucianò R, Shariat SF, Guazzoni G, Gaboardi F, Montorsi F, Briganti A.

Urol Oncol. 2016 Feb;34(2):57.e1-7. doi: 10.1016/j.urolonc.2015.08.019. Epub 2015 Oct 1.

PMID:
26427694
28.

Tenascin-C Protects Cancer Stem-like Cells from Immune Surveillance by Arresting T-cell Activation.

Jachetti E, Caputo S, Mazzoleni S, Brambillasca CS, Parigi SM, Grioni M, Piras IS, Restuccia U, Calcinotto A, Freschi M, Bachi A, Galli R, Bellone M.

Cancer Res. 2015 May 15;75(10):2095-108. doi: 10.1158/0008-5472.CAN-14-2346. Epub 2015 Mar 25.

29.

Impact of stage migration and practice changes on high-risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades.

Fossati N, Passoni NM, Moschini M, Gandaglia G, Larcher A, Freschi M, Guazzoni G, Sjoberg DD, Vickers AJ, Montorsi F, Briganti A.

BJU Int. 2016 May;117(5):740-7. doi: 10.1111/bju.13125. Epub 2015 Jun 10.

30.

Oncological predictive value of the 2004 World Health Organisation grading classification in primary T1 non-muscle-invasive bladder cancer. A step forward or back?

Pellucchi F, Freschi M, Moschini M, Rocchini L, Maccagnano C, Nazareno S, Bergamaschi F, Montorsi F, Colombo R.

BJU Int. 2015 Feb;115(2):267-73.

PMID:
25756136
31.

Silodosin and tadalafil have synergistic inhibitory effects on nerve-mediated contractions of human and rat isolated prostates.

Buono R, Briganti A, Freschi M, Villa L, La Croce G, Moschini M, Benigni F, Castiglione F, Montorsi F, Hedlund P.

Eur J Pharmacol. 2014 Dec 5;744:42-51. doi: 10.1016/j.ejphar.2014.09.030. Epub 2014 Sep 23.

PMID:
25261033
32.

Onset of hydronephrosis and lower urinary tract symptoms in a previously healthy young man: Phyllodes tumour of the prostate as a potential diagnosis.

Ferrari M, Capitanio U, Rizzo N, Freschi M, Montorsi F, Rigatti P.

Can Urol Assoc J. 2014 Jul;8(7-8):E561-3. doi: 10.5489/cuaj.1984.

33.

Preoperative Prostate-specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer: Results from a Multicentric European Prospective Study.

Fossati N, Buffi NM, Haese A, Stephan C, Larcher A, McNicholas T, de la Taille A, Freschi M, Lughezzani G, Abrate A, Bini V, Palou Redorta J, Graefen M, Guazzoni G, Lazzeri M.

Eur Urol. 2015 Jul;68(1):132-8. doi: 10.1016/j.eururo.2014.07.034. Epub 2014 Aug 16.

PMID:
25139197
34.

Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients.

Ploussard G, Isbarn H, Briganti A, Sooriakumaran P, Surcel CI, Salomon L, Freschi M, Mirvald C, van der Poel HG, Jenkins A, Ost P, van Oort IM, Yossepowitch O, Giannarini G, van den Bergh RC; Members of the Prostate Cancer Working Group of the Young Academic Urologists Working Party of the European Association of Urology.

Urol Oncol. 2015 Feb;33(2):71.e1-9. doi: 10.1016/j.urolonc.2014.07.007. Epub 2014 Aug 15.

PMID:
25131660
35.

Clinical performance of the Prostate Health Index (PHI) for the prediction of prostate cancer in obese men: data from the PROMEtheuS project, a multicentre European prospective study.

Abrate A, Lazzeri M, Lughezzani G, Buffi N, Bini V, Haese A, de la Taille A, McNicholas T, Redorta JP, Gadda GM, Lista G, Kinzikeeva E, Fossati N, Larcher A, Dell'Oglio P, Mistretta F, Freschi M, Guazzoni G.

BJU Int. 2015 Apr;115(4):537-45. doi: 10.1111/bju.12907.

36.

The number of cores at first biopsy may suggest the need for a confirmatory biopsy in patients eligible for active surveillance-implication for clinical decision making in the real-life setting.

Villa L, Salonia A, Capitanio U, Scattoni V, Abdollah F, Suardi N, Dell'Oglio P, Freschi M, Montorsi F, Briganti A.

Urology. 2014 Sep;84(3):634-41. doi: 10.1016/j.urology.2014.02.070. Epub 2014 Jul 22.

PMID:
25059594
37.

Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer.

Orfanelli U, Jachetti E, Chiacchiera F, Grioni M, Brambilla P, Briganti A, Freschi M, Martinelli-Boneschi F, Doglioni C, Montorsi F, Bellone M, Casari G, Pasini D, Lavorgna G.

Oncogene. 2015 Apr 16;34(16):2094-102. doi: 10.1038/onc.2014.144. Epub 2014 Jun 16.

PMID:
24931166
38.

GastroPanel® test for non-invasive diagnosis of atrophic gastritis in patients with dyspepsia.

Masci E, Pellicano R, Mangiavillano B, Luigiano C, Stelitano L, Morace C, Viale E, Freschi M, Locatelli M, Ieri R, Cavallaro A, Testoni S, Testoni PA.

Minerva Gastroenterol Dietol. 2014 Mar;60(1):79-83.

PMID:
24632770
39.

ISMuLT Guidelines for muscle injuries.

Maffulli N, Oliva F, Frizziero A, Nanni G, Barazzuol M, Via AG, Ramponi C, Brancaccio P, Lisitano G, Rizzo D, Freschi M, Galletti S, Melegati G, Pasta G, Testa V, Valent A, Del Buono A.

Muscles Ligaments Tendons J. 2014 Feb 24;3(4):241-9. eCollection 2013 Oct.

40.

Relationship of chronic histologic prostatic inflammation in biopsy specimens with serum isoform [-2]proPSA (p2PSA), %p2PSA, and prostate health index in men with a total prostate-specific antigen of 4-10 ng/ml and normal digital rectal examination.

Lazzeri M, Abrate A, Lughezzani G, Gadda GM, Freschi M, Mistretta F, Lista G, Fossati N, Larcher A, Kinzikeeva E, Buffi N, Dell'Acqua V, Bini V, Montorsi F, Guazzoni G.

Urology. 2014 Mar;83(3):606-12. doi: 10.1016/j.urology.2013.10.016. Epub 2013 Dec 6.

PMID:
24315305
41.

Percentage of high-grade tumour volume does not meaningfully improve prediction of early biochemical recurrence after radical prostatectomy compared with Gleason score.

Hansen J, Bianchi M, Sun M, Rink M, Castiglione F, Abdollah F, Steuber T, Ahyai SA, Steurer S, Göbel C, Freschi M, Montorsi F, Shariat SF, Fisch M, Graefen M, Karakiewicz PI, Briganti A, Chun FK.

BJU Int. 2014 Mar;113(3):399-407. doi: 10.1111/bju.12424. Epub 2013 Dec 2.

42.

Gene signatures distinguish stage-specific prostate cancer stem cells isolated from transgenic adenocarcinoma of the mouse prostate lesions and predict the malignancy of human tumors.

Mazzoleni S, Jachetti E, Morosini S, Grioni M, Piras IS, Pala M, Bulfone A, Freschi M, Bellone M, Galli R.

Stem Cells Transl Med. 2013 Sep;2(9):678-89. doi: 10.5966/sctm.2013-0041. Epub 2013 Jul 24.

43.

Utility of [11C]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: results from a pathologically validated series.

Passoni NM, Suardi N, Abdollah F, Picchio M, Giovacchini G, Messa C, Freschi M, Montorsi F, Briganti A.

Urol Oncol. 2014 Jan;32(1):38.e9-16. doi: 10.1016/j.urolonc.2013.03.006. Epub 2013 Jun 13.

PMID:
23769269
44.

Prostate cancer stem cells are targets of both innate and adaptive immunity and elicit tumor-specific immune responses.

Jachetti E, Mazzoleni S, Grioni M, Ricupito A, Brambillasca C, Generoso L, Calcinotto A, Freschi M, Mondino A, Galli R, Bellone M.

Oncoimmunology. 2013 May 1;2(5):e24520. Epub 2013 Apr 16.

45.

Vaccine-instructed intratumoral IFN-γ enables regression of autochthonous mouse prostate cancer in allogeneic T-cell transplantation.

Hess Michelini R, Manzo T, Sturmheit T, Basso V, Rocchi M, Freschi M, Listopad J, Blankenstein T, Bellone M, Mondino A.

Cancer Res. 2013 Aug 1;73(15):4641-52. doi: 10.1158/0008-5472.CAN-12-3464. Epub 2013 Jun 7.

46.

Kidney endometriosis.

Maccagnano C, Freschi M, Ghezzi M, Rocchini L, Pellucchi F, Rigatti P, Montorsi F, Colombo R.

Minerva Urol Nefrol. 2013 Jun;65(2):157-9. No abstract available.

PMID:
23703102
47.

Complications and quality of life after template-assisted transperineal prostate biopsy in patients eligible for focal therapy.

Losa A, Gadda GM, Lazzeri M, Lughezzani G, Cardone G, Freschi M, Lista G, Larcher A, Nava LD, Guazzoni G.

Urology. 2013 Jun;81(6):1291-6. doi: 10.1016/j.urology.2012.11.078. Epub 2013 Mar 19.

PMID:
23522299
48.

Head-to-head comparison of lymph node density and number of positive lymph nodes in stratifying the outcome of patients with lymph node-positive prostate cancer submitted to radical prostatectomy and extended lymph node dissection.

Passoni NM, Abdollah F, Suardi N, Gallina A, Bianchi M, Tutolo M, Fossati N, Gandaglia G, Salonia A, Freschi M, Rigatti P, Montorsi F, Briganti A.

Urol Oncol. 2014 Jan;32(1):29.e21-8. doi: 10.1016/j.urolonc.2012.10.009. Epub 2013 Mar 13.

PMID:
23490908
49.

Serum isoform [-2]proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2-10 ng/ml: a multicentric European study.

Lazzeri M, Haese A, de la Taille A, Palou Redorta J, McNicholas T, Lughezzani G, Scattoni V, Bini V, Freschi M, Sussman A, Ghaleh B, Le Corvoisier P, Alberola Bou J, Esquena Fernández S, Graefen M, Guazzoni G.

Eur Urol. 2013 Jun;63(6):986-94. doi: 10.1016/j.eururo.2013.01.011. Epub 2013 Jan 24.

PMID:
23375961
50.

The number of cores taken in patients diagnosed with a single microfocus at initial biopsy is a major predictor of insignificant prostate cancer.

Villa L, Capitanio U, Briganti A, Abdollah F, Suardi N, Salonia A, Gallina A, Freschi M, Russo A, Castiglione F, Bianchi M, Rigatti P, Montorsi F, Scattoni V.

J Urol. 2013 Mar;189(3):854-9. doi: 10.1016/j.juro.2012.09.100. Epub 2012 Sep 25.

PMID:
23022004

Supplemental Content

Loading ...
Support Center